Interleukin-5 is produced by a number of cell types, and is responsible for
the maturation and release of eosinophils in the bone marrow. In humans, i
nterleukin-5 is a very selective cytokine as a result of the restricted exp
ression of the interleukin-5 receptor on eosinophils and basophils. Eosinop
hils are a prominent feature in the pulmonary inflammation that is associat
ed with allergic airway diseases, suggesting that inhibition of interleukin
-5 is a viable treatment. The present review addresses the data that relate
interleukin-5 to pulmonary inflammation and function in animal models, and
the use of neutralizing anti-interleukin-5 monoclonal antibodies for the t
reatment of asthma in humans.